Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France

被引:78
作者
Tu Anh Duong [1 ]
Sbidian, Emilie [1 ,2 ,3 ]
Valeyrie-Allanore, Laurence [1 ,2 ,4 ]
Vialette, Cedric [5 ]
Ferkal, Salah [3 ,4 ,6 ]
Hadj-Rabia, Smail [7 ]
Glorion, Christophe [8 ]
Lyonnet, Stanislas [9 ]
Zerah, Michel [10 ]
Kemlin, Isabelle [11 ]
Rodriguez, Diana [11 ,12 ]
Bastuji-Garin, Sylvie [2 ,3 ,4 ]
Wolkenstein, Pierre [1 ,2 ,4 ]
机构
[1] Hop Henri Mondor, Serv Dermatol, AP HP, F-94010 Creteil, France
[2] Univ Paris Est, LIC EA4393, Lab Invest Clin, F-94010 Creteil, France
[3] Hop Henri Mondor, Pole Rech Clin Sante Publ, AP HP, F-94010 Creteil, France
[4] Hop Henri Mondor, Ctr Reference Neurofibromatoses, AP HP, F-94010 Creteil, France
[5] Hop Henri Mondor, Unite Rech Clin, AP HP, F-94010 Creteil, France
[6] Univ Paris Est, INSERM, Ctr Invest Clin 006, F-94010 Creteil, France
[7] Univ Paris 05, Hop Necker Enfants Malad, Serv Dermatol, Ctr Reference Maladies Genet & Express Cutanee,A, F-75743 Paris, France
[8] Hop Necker Enfants Malad, Serv Orthopedie, AP HP, F-75743 Paris, France
[9] Hop Necker Enfants Malad, Serv Genet, AP HP, F-75743 Paris, France
[10] Hop Necker Enfants Malad, Serv Neurochirurg, AP HP, F-75743 Paris, France
[11] Hop Trousseau, Serv Neuropediat, AP HP, F-75571 Paris, France
[12] Univ Paris 06, Paris, France
关键词
NERVE SHEATH TUMORS; TYPE-1;
D O I
10.1186/1750-1172-6-18
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown in one study to be associated with a 15-year decrease in life expectancy. However, data on mortality in NF1 are limited. Our aim was to evaluate mortality in a large retrospective cohort of NF1 patients seen in France between 1980 and 2006. Methods: Consecutive NF1 patients referred to the National French Referral Center for Neurofibromatoses were included. The standardized mortality ratio (SMR) with its 95% confidence interval (CI) was calculated as the ratio of observed over expected numbers of deaths. We studied factors associated with death and causes of death. Results: Between 1980 and 2006, 1895 NF1 patients were seen. Median follow-up was 6.8 years (range, 0.4-20.6). Vital status was available for 1226 (65%) patients, of whom 1159 (94.5%) survived and 67 (5.5%) died. Overall mortality was significantly increased in the NF1 cohort (SMR, 2.02; CI, 1.6-2.6; P < 10(-4)). The excess mortality occurred among patients aged 10 to 20 years (SMR, 5.2; CI, 2.6-9.3; P < 10(-4)) and 20 to 40 years (SMR, 4.1; 2.8-5.8; P < 10(-4)). Significant excess mortality was found in both males and females. In the 10-20 year age group, females had a significant increase in mortality compared to males (SMR, 12.6; CI, 5.7-23.9; and SMR, 1.8; CI, 0.2-6.4; respectively). The cause of death was available for 58 (86.6%) patients; malignant nerve sheath tumor was the main cause of death (60%). Conclusions: We found significantly increased SMRs indicating excess mortality in NF1 patients compared to the general population. The definitive diagnosis of NF1 in all patients is a strength of our study, and the high rate of death related to malignant transformation is consistent with previous work. The retrospective design and hospital-based recruitment are limitations of our study. Mortality was significantly increased in NF1 patients aged 10 to 40 years and tended to be higher in females than in males.
引用
收藏
页数:8
相关论文
共 20 条
[1]  
Breslow N E, 1987, IARC Sci Publ, P1
[2]   Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner [J].
Byer, Stephanie J. ;
Eckert, Jenell M. ;
Brossier, Nicole M. ;
Clodfelder-Miller, Buffie J. ;
Turk, Amy N. ;
Carroll, Andrew J. ;
Kappes, John C. ;
Zinn, Kurt R. ;
Prasain, Jeevan K. ;
Carroll, Steven L. .
NEURO-ONCOLOGY, 2011, 13 (01) :28-41
[3]   Malignant peripheral nerve sheath tumours in neurofibromatosis 1 [J].
Evans, DGR ;
Baser, ME ;
McGaughran, J ;
Sharif, S ;
Howard, E ;
Moran, A .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) :311-314
[4]  
Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO
[5]  
2-U
[6]   A GENETIC-STUDY OF VONRECKLINGHAUSEN NEUROFIBROMATOSIS IN SOUTH EAST WALES .1. PREVALENCE, FITNESS, MUTATION-RATE, AND EFFECT OF PARENTAL TRANSMISSION ON SEVERITY [J].
HUSON, SM ;
COMPSTON, DAS ;
CLARK, P ;
HARPER, PS .
JOURNAL OF MEDICAL GENETICS, 1989, 26 (11) :704-711
[7]  
Imaizumi Yoko, 1995, Journal of Dermatology (Tokyo), V22, P191
[8]   Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients 2 [J].
Khosrotehrani, K ;
Bastuji-Garin, S ;
Riccardi, VM ;
Birch, P ;
Friedman, JM ;
Wolkenstein, P .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 132A (01) :49-53
[9]   Clinical risk factors for mortality in patients with neurofibromatosis 1 - A cohort study of 378 patients [J].
Khosrotehrani, K ;
Bastuji-Garin, S ;
Zeller, J ;
Revuz, J ;
Wolkenstein, P .
ARCHIVES OF DERMATOLOGY, 2003, 139 (02) :187-191
[10]   Analysis of steroid hormone effects on xenografted human NF1 tumor Schwann cells [J].
Li, Hua ;
Zhang, Xuelian ;
Fishbein, Lauren ;
Kweh, Frederick ;
Thompson, Martha Campbell ;
Perrin, George Q. ;
Muir, David ;
Wallace, Margaret .
CANCER BIOLOGY & THERAPY, 2010, 10 (08) :758-764